Entheon Biomedical (XCNQ:ENBI.X) EPS (Basic): C$0.00 (TTM As of Feb. 2026)


What is Entheon Biomedical EPS (Basic)?

Entheon Biomedical XCNQ:ENBI.X EPS (Basic) is C$0.00 as of Feb. 2026. The stock has 2 warning signs investors should review.

Entheon Biomedical's basic earnings per share (Basic EPS) for the three months ended in Feb. 2026 was C$0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Feb. 2026 was C$0.00.

Entheon Biomedical's EPS (Diluted) for the three months ended in Feb. 2026 was C$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was C$0.00.

Entheon Biomedical's EPS without NRI for the three months ended in Feb. 2026 was C$0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2026 was 0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 61.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 51.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Entheon Biomedical's highest 3-Year average EPS without NRI Growth Rate was 70.40% per year. The lowest was -263.40% per year. And the median was 20.20% per year.

Entheon Biomedical  (XCNQ:ENBI.X) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Entheon Biomedical EPS (Basic) Related Terms

Entheon Biomedical EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical EPS (Basic) Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only -1.60 -1.44 -0.05 -0.04 -0.02

Entheon Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.00 0.00 0.00 0.00

Entheon Biomedical EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Entheon Biomedical's Basic EPS for the fiscal year that ended in Nov. 2025 is calculated as

Basic EPS (A: Nov. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.324-0)/13.407
=-0.02

Entheon Biomedical's Basic EPS for the quarter that ended in Feb. 2026 is calculated as

Basic EPS (Q: Feb. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.1-0)/20.608
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of C$0.00 mean?
Entheon Biomedical (XCNQ:ENBI.X) has a EPS (Basic) of C$0.00 as of Feb. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Entheon Biomedical and its competitors.
Is Entheon Biomedical's EPS (Basic) too high?
Entheon Biomedical's current EPS (Basic) is C$0.00.
How does Entheon Biomedical's EPS (Basic) compare to VRTX and REGN?
Entheon Biomedical's EPS (Basic) of C$0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Entheon Biomedical and its competitors. Entheon Biomedical's current EPS (Basic) is C$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (XCNQ:ENBI.X) has a current EPS (Basic) of C$0.00. The current EPS (Basic) is C$0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Entheon Biomedical (XCNQ:ENBI.X), the current EPS (Basic) is C$0.00 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges ENTBF:USA1XU:Germany
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.